Search Results 1071-1080 of 17873 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

  2. COVID and Diabetes Assessment - Clinical Trials

    ... monoclonal antibody used for treatment) in 365 days prior to diagnosis ... (Patients who report COVID- status will also have SARS-CoV-2 nucleocapsid antibody ...

  3. Nonmelanoma Skin Cancer Clinical Trials - Mayo Clinic Research

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  4. Atypical cells: Are they cancer? - Mayo Clinic

    Monoclonal antibody medicines for cancer: How they work · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · MRI · Needle biopsy ...

  5. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

    ... monoclonal antibodies): 2 weeks; Immune-checkpoint inhibitors (i.e., anti-PD-1, anti-PD-L1, or anti-CTLA-4): 4 weeks; Other monoclonal antibodies, antibody ...

  6. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

    We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor that significantly reduces the ...

  7. A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors - Mayo Clinic

    composition to monoclonal antibodies or any excipient of HFB301001; - Known active malignancy, with the exception of the specific cancer under investigation

  8. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... antibody Patients in Expansion Phase, Cohorts 2 and 3; Previously ... Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to baseline ...

  9. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Has had a prior monoclonal antibody within 4 weeks prior to study Day 1 or ... antibody (including ipilimumab or any other antibody or drug ...

  10. COVID19 Immunology and Omics Study - Clinical Trials

    Individuals who are recieving a monoclonal antibody infusion. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...